Detalles de la búsqueda
1.
Prevalence and Impact of Frailty in Patients ≥70 Years Old with Acute Coronary Syndrome Referred for Coronary Angiography.
Cardiology
; 149(1): 1-13, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952523
2.
International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia - ISCHEMIA-CTO trial - rationale and design.
Am Heart J
; 257: 41-50, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36423733
3.
Scar border zone mass and presence of border zone channels assessed with cardiac magnetic resonance imaging are associated with ventricular arrhythmia in patients with ST-segment elevation myocardial infarction.
Europace
; 25(3): 978-988, 2023 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36576342
4.
The benefit of complete revascularization after primary PCI for STEMI is attenuated by increasing age: Results from the DANAMI-3-PRIMULTI randomized study.
Catheter Cardiovasc Interv
; 97(4): E467-E474, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32681717
5.
Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas Project.
Eur Heart J
; 41(27): 2579-2588, 2020 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32584388
6.
Correction to: Pilot study of the multicentre DISCHARGE trial: image quality and protocol adherence results of computed tomography and invasive coronary angiography.
Eur Radiol
; 30(9): 5223-5225, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32333145
7.
Pilot study of the multicentre DISCHARGE Trial: image quality and protocol adherence results of computed tomography and invasive coronary angiography.
Eur Radiol
; 30(4): 1997-2009, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31844958
8.
Electrocardiogram to predict reperfusion success in late presenters with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
J Electrocardiol
; 59: 74-80, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32007909
9.
Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study.
Am Heart J
; 204: 128-138, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30103092
10.
Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.
Eur Heart J
; 38(6): 413-421, 2017 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27941018
11.
Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.
Lancet
; 387(10034): 2199-206, 2016 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27053444
12.
Association of common genetic variants related to atrial fibrillation and the risk of ventricular fibrillation in the setting of first ST-elevation myocardial infarction.
BMC Med Genet
; 18(1): 138, 2017 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29162046
13.
Invasive angiography and revascularization in patients with stable angina following prior coronary artery bypass grafting: Results from the East Denmark heart registry.
Catheter Cardiovasc Interv
; 89(3): 341-349, 2017 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27219901
14.
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3PRIMULTI): an open-label, randomised controlled trial.
Lancet
; 386(9994): 665-71, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26347918
15.
Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.
Lancet
; 385(9977): 1527-35, 2015 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25601789
16.
Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.
Lancet
; 383(9934): 2047-2056, 2014 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24631162
17.
Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction.
Am Heart J
; 170(1): 70-8, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26093866
18.
The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only: Rationale and design of the DANAMI 3 trial program.
Am Heart J
; 169(5): 613-21, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25965708
19.
A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).
Catheter Cardiovasc Interv
; 86(7): 1161-7, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25640050
20.
Decreased patency rates following endoscopic vein harvest in coronary artery bypass surgery.
Scand Cardiovasc J
; 49(5): 286-92, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26053411